Global Ganja Report

The arrest of a Rudolph Giuliani associate on suspicion of influence-peddling related to the cannabis industry has opened a window into the sleazy underside of the business. Sacramento's mayor has called for an investigation, and the FBI is said to be conducting its own probe. Legalization was supposed to take cannabis out of the hands of criminal networks, but the new model often looks like crony capitalism.

New York's Gov. Cuomo is broaching a cannabis common market for the tri-state area, joining with New Jersey and Connecticut to harmonize regulations and even cooperate in joint purchasing. But the move is being considered partly as a reaction to the vaping scare, and official statements reveal some dangerous confusion as to the distinction between vaping cannabis extracts and smoking actual cannabis.

The Trump administration has issued rules allowing drug tests (including for cannabis, of course) for those receiving unemployment benefits. But as more states embrace legalization, pressure is mounting to do away with cannabis testing for workers altogether.

A ground-breaking study is set to begin in Australia, to determine if cannabis can improve the quality of life of those suffering from dementia. Elderly care facilities are watching closely, hoping cannabis will prove a key to help those they look after lead happier lives, with less medication.

So-called "smokable hemp" is suddenly available in shops from coast to coast, legal under terms of last year's Farm Bill. But law enforcement is consternated, conservative politicians are apoplectic, and legislation is being prepared to ban the stuff at the state level. Is this permissible under federal law?

A federal appeals court in Denver has held that protections under the Fair Labor Standards Act apply to "all workers"—including those in the cannabis industry. The ruling sets an important precedent, boosting efforts to unionize the new legal industry.

Researchers are exploring the connection between cannabinoids and dopamine in the human brain, and particularly how THC affects our "reward system"—key to such phenomena as motivation, addiction and euphoria. Investigations are revealing both potential for treatments of psychiatric disorders as well as possible risks from heavy use, especially among the young.

Health authorities have named Vitamin E acetate as a likely suspect in the serious illness that has now affected hundreds across the country after vaping either cannabis or tobacco products. In many of the cases illicit-market dab carts appear to be responsible for the severe pulmonary problems that have now resulted in five deaths. But public authorities and the cannabis industry alike caution that research is ongoing.